Uncovering the PI3Ksome: Phosphoinositide 3-Kinases and Counteracting PTEN Form a Signaling Complex with Intrinsic Regulatory Properties

REFERENCES

• Fruman DA, Rommel C. 2014. PI3K and cancer: lessons, challenges and opportunities. Nat. Rev. Drug Discov. 13:140–156. http://dx.doi.org/10.1038/nrd4204.
   PubMed Web of Science ®Google Scholar
• Huang YH, Sauer K. 2010. Lipid signaling in T-cell development and function. Cold Spring Harb. Perspect. Biol. 2:a002428. http://dx.doi.org/10.1101/cshperspect.a002428.
   PubMedGoogle Scholar
• Song MS, Salmena L, Pandolfi PP. 2012. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13:283–296. http://dx.doi.org/10.1038/nrm3330.
   PubMed Web of Science ®Google Scholar
• Pérez-García V, Redondo-Muñoz J, Kumar A, Carrera AC. 2014. Cell activated-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity. Mol. Cell. Biol. 34:3359–3373. http://dx.doi.org/10.1128/MCB.00167-14.
   PubMedGoogle Scholar
• Geering B, Cutillas PR, Vanhaesebroeck B. 2007. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? Biochem. Soc. Trans. 35:199–203. http://dx.doi.org/10.1042/BST0350199.
   PubMedGoogle Scholar
• Layton MJ, Harpur AG, Panayotou G, Bastiaens PI, Waterfield MD. 1998. Binding of a diphosphotyrosine-containing peptide that mimics activated platelet-derived growth factor receptor beta induces oligomerization of phosphatidylinositol 3-kinase. J. Biol. Chem. 273:33379–33385. http://dx.doi.org/10.1074/jbc.273.50.33379.
   PubMedGoogle Scholar
• Harpur AG, Layton MJ, Das P, Bottomley MJ, Panayotou G, Driscoll PC, Waterfield MD. 1999. Intermolecular interactions of the p85α regulatory subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 274:12323–12332. http://dx.doi.org/10.1074/jbc.274.18.12323.
   PubMed Web of Science ®Google Scholar
• Rabinovsky R, Pochanard P, McNear C, Brachmann SM, Duke-Cohan JS, Garraway LA, Sellers WR. 2009. p85 associates with unphosphorylated PTEN and the PTEN-associated complex. Mol. Cell. Biol. 29:5377–5388. http://dx.doi.org/10.1128/MCB.01649-08.
   PubMed Web of Science ®Google Scholar
• Chagpar RB, Links PH, Pastor MC, Furber LA, Hawrysh AD, Chamberlain MD, Anderson DH. 2010. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U. S. A. 107:5471–5476. http://dx.doi.org/10.1073/pnas.0908899107.
   PubMed Web of Science ®Google Scholar
• Kestler HA, Wawra C, Kracher B, Kühl M. 2008. Network modeling of signal transduction: establishing the global view. Bioessays 30:1110–1125. http://dx.doi.org/10.1002/bies.20834.
   PubMedGoogle Scholar
• Mukherjee S, Rigaud S, Seok SC, Fu G, Prochenka A, Dworkin M, Gascoigne NR, Vieland VJ, Sauer K, Das J. 2013. In silico modeling of Itk activation kinetics in thymocytes suggests competing positive and negative IP4 mediated feedbacks increase robustness. PLoS One 8:e73937. http://dx.doi.org/10.1371/journal.pone.0073937.
   PubMedGoogle Scholar
• Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E. 2005. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J. 19:115–117. http://dx.doi.org/10.1096/fj.04-1942fje.
   PubMed Web of Science ®Google Scholar
• Le Floc'h A, Tanaka Y, Bantilan NS, Voisinne G, Altan-Bonnet G, Fukui Y, Huse M. 2013. Annular PIP3 accumulation controls actin architecture and modulates cytotoxicity at the immunological synapse. J. Exp. Med. 210:2721–2737. http://dx.doi.org/10.1084/jem.20131324.
   PubMedGoogle Scholar
• Miletic AV, Anzelon-Mills AN, Mills DM, Omori SA, Pedersen IM, Shin DM, Ravetch JV, Bolland S, Morse HCIII, Rickert RC. 2010. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J. Exp. Med. 207:2407–2420. http://dx.doi.org/10.1084/jem.20091962.
   PubMed Web of Science ®Google Scholar
• Cheung LW, Hennessy BT, Li J, Yu S, Myers AP, Djordjevic B, Lu Y, Stemke-Hale K, Dyer MD, Zhang F, Ju Z, Cantley LC, Scherer SE, Liang H, Lu KH, Broaddus RR, Mills GB. 2011. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov. 1:170–185. http://dx.doi.org/10.1158/2159-8290.CD-11-0039.
   PubMed Web of Science ®Google Scholar
• Barber DF, Alvarado-Kristensson M, Gonzalez-Garcia A, Pulido R, Carrera AC. 2006. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase. Sci. STKE 2006:pe49. http://dx.doi.org/10.1126/stke.3622006pe49.
   PubMedGoogle Scholar
• Taniguchi CM, Tran TT, Kondo T, Luo J, Ueki K, Cantley LC, Kahn CR. 2006. Phosphoinositide 3-kinase regulatory subunit p85α suppresses insulin action via positive regulation of PTEN. Proc. Natl. Acad. Sci. U. S. A. 103:12093–12097. http://dx.doi.org/10.1073/pnas.0604628103.
   PubMed Web of Science ®Google Scholar